Document is current
Any future updates will be listed below
-
Authors
Ouanes, Sami
Rabl, Miriam
Clark, Christopher
Kirschbaum, Clemens
Popp, Julius
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_141179)
Stiftung Synapsis - Alzheimer Forschung Schweiz AFS (2017-PI01)
- License Information
-
More Information
Article History
Received: 27 August 2022
Accepted: 6 December 2022
First Online: 19 December 2022
Declarations
:
: The Vaud Cantonal Commission on Ethics in Human Research approved this study (No. 171/2013), and all participants or their legal representatives provided written informed consent.
: Not applicable.
: JP received consultation honoraria from Nestle Institute of Health Sciences, Innovation Campus, EPFL, Lausanne, Switzerland; Ono Pharma; OM Pharma; and Fujirebio Europe, all unrelated to the present work. The other authors declare no potential conflicts of interest.
